These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33593844)

  • 1.
    Clayton NP; Jain A; Halasohoris SA; Pysz LM; Lembirik S; Zumbrun SD; Kane CD; Hackett MJ; Pfefferle D; Smiley MA; Anderson MS; Heine H; Meister GT; Pucci MJ
    Antimicrob Agents Chemother; 2021 May; 65(5):. PubMed ID: 33593844
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Steenbergen J; Tanaka SK; Miller LL; Halasohoris SA; Hershfield JR
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Class A β-Lactamase Produced by
    Becka SA; Zeiser ET; LiPuma JJ; Papp-Wallace KM
    Antibiotics (Basel); 2022 May; 11(5):. PubMed ID: 35625319
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Cotroneo N; Rubio A; Critchley IA; Pillar C; Pucci MJ
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32423950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Gupta V; Ek A; Srivastava P; Talley A; Bruss J
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0059022. PubMed ID: 35762796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, Pharmacokinetics, and Food Effect of Tebipenem Pivoxil Hydrobromide after Single and Multiple Ascending Oral Doses in Healthy Adult Subjects.
    Eckburg PB; Jain A; Walpole S; Moore G; Utley L; Manyak E; Dane A; Melnick D
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tebipenem pivoxil hydrobromide-No PICC, no problem!
    Sodhi V; Kronsberg KA; Clark M; Cho JC
    Pharmacotherapy; 2021 Sep; 41(9):748-761. PubMed ID: 34370326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Tebipenem Hydrolysis by β-Lactamases Prevalent in Complicated Urinary Tract Infections.
    Sun Z; Su L; Cotroneo N; Critchley I; Pucci M; Jain A; Palzkill T
    Antimicrob Agents Chemother; 2022 May; 66(5):e0239621. PubMed ID: 35491852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening.
    McLaughlin HP; Sue D
    BMC Microbiol; 2018 Dec; 18(1):218. PubMed ID: 30563467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study of the Effects of Tebipenem Pivoxil Hydrobromide on QT/QTc Intervals in Healthy Subjects.
    Gupta VK; Maier G; Eckburg P; Morelli L; Lei Y; Jain A; Manyak E; Melnick D
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0014521. PubMed ID: 33875429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary Evaluation of Tebipenem
    Mendes RE; Arends SJR; Streit JM; Critchley I; Cotroneo N; Castanheira M
    Microbiol Spectr; 2023 Feb; 11(1):e0205722. PubMed ID: 36625644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection.
    Eckburg PB; Muir L; Critchley IA; Walpole S; Kwak H; Phelan AM; Moore G; Jain A; Keutzer T; Dane A; Melnick D; Talley AK
    N Engl J Med; 2022 Apr; 386(14):1327-1338. PubMed ID: 35388666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil Hydrobromide.
    Ganesan H; Gupta VK; Safir MC; Bhavnani SM; Talley AK; Melnick D; Rubino CM
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0145122. PubMed ID: 37191505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial.
    Sewunet T; Razavi M; Rosenborg S; Camporeale A; Nowak M; Melnick D; Gasink LB; Eckburg PB; Critchley IA; Nord CE; Giske CG
    Lancet Microbe; 2024 Apr; 5(4):e355-e365. PubMed ID: 38432233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Activity Evaluation of Tebipenem (SPR859), an Orally Available Carbapenem, against a Global Set of Enterobacteriaceae Isolates, Including a Challenge Set of Organisms.
    Arends SJR; Rhomberg PR; Cotroneo N; Rubio A; Flamm RK; Mendes RE
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption, Metabolism, and Excretion of [
    Gupta VK; Maier G; Gasink L; Ek A; Fudeman M; Srivastava P; Talley A
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0150922. PubMed ID: 36995239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of Oral Tebipenem Pivoxil Hydrobromide in Subjects with Various Degrees of Renal Impairment.
    Patel G; Rodvold KA; Gupta VK; Bruss J; Gasink L; Bajraktari F; Lei Y; Jain A; Srivastava P; Talley AK
    Antimicrob Agents Chemother; 2022 May; 66(5):e0240721. PubMed ID: 35420493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinations of early generation antibiotics and antimicrobial peptides are effective against a broad spectrum of bacterial biothreat agents.
    Cote CK; Blanco II; Hunter M; Shoe JL; Klimko CP; Panchal RG; Welkos SL
    Microb Pathog; 2020 Feb; 142():104050. PubMed ID: 32050093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens,
    Tao P; Mahalingam M; Zhu J; Moayeri M; Kirtley ML; Fitts EC; Andersson JA; Lawrence WS; Leppla SH; Chopra AK; Rao VB
    Front Immunol; 2017; 8():687. PubMed ID: 28694806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.